Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Human ELMO1, N-His

Recombinant Human ELMO1, N-His from ProteoGenix; catalogue ARO-P12900; research use only.

SKU:
ABM143340-1
Manufacturer SKU
ARO-P12900
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Introduction

Recombinant Human ELMO1, also known as Engulfment and Cell Motility protein 1, is a protein that plays a crucial role in cell migration and phagocytosis. It is a member of the ELMO protein family, which is involved in regulating the activity of the small GTPase Rac during cell movement. Recombinant Human ELMO1 is a valuable tool in scientific research and has potential applications in various fields, including immunology and cancer research.

Structure of Recombinant Human ELMO1

Recombinant Human ELMO1 is a 98 kDa protein composed of 884 amino acids. It contains several domains, including an N-terminal ELMO domain, a PH domain, and a C-terminal SH3 domain. The ELMO domain is responsible for binding to the small GTPase Rac, while the PH domain is involved in membrane localization. The SH3 domain is important for protein-protein interactions and is responsible for binding to other signaling proteins.

Activity of Recombinant Human ELMO1

Recombinant Human ELMO1 plays a critical role in cell migration and phagocytosis by regulating the activity of Rac. Rac is a small GTPase that controls actin polymerization and cytoskeletal rearrangement, which are essential processes for cell movement. By binding to Rac, Recombinant Human ELMO1 activates Rac and promotes its localization to the leading edge of migrating cells. This results in the formation of lamellipodia, which are thin, sheet-like protrusions that facilitate cell movement.

In addition to its role in cell migration, Recombinant Human ELMO1 also plays a crucial role in phagocytosis, the process by which cells engulf and digest foreign particles. It promotes the formation of phagocytic cups, which are cup-shaped structures that surround the target particle and facilitate its uptake by the cell. Recombinant Human ELMO1 also interacts with other proteins involved in phagocytosis, such as DOCK1 and CRKII, to regulate the activity of Rac and promote efficient phagocytosis.

Applications of Recombinant Human ELMO1

Recombinant Human ELMO1 has a wide range of applications in scientific research. Its role in cell migration and phagocytosis makes it a valuable tool for studying these processes. It can be used to investigate the mechanisms of cell movement and to identify potential therapeutic targets for diseases that involve abnormal cell migration, such as cancer metastasis.

In immunology research, Recombinant Human ELMO1 can be used to study the role of phagocytosis in the immune response. It can also be used to investigate the signaling pathways involved in phagocytosis and to identify potential therapeutic targets for diseases that involve impaired phagocytosis, such as autoimmune disorders.

Furthermore, Recombinant Human ELMO1 has potential applications in drug discovery. As it plays a critical role in cell migration, it can be targeted for the development of drugs that inhibit or promote cell movement, depending on the desired outcome. This could have implications for various diseases, including cancer, where inhibiting cell migration could prevent metastasis, and promoting cell migration could aid in tissue repair.

Conclusion

Recombinant Human ELMO1 is a crucial protein involved in cell migration and phagocytosis. Its structure and activity make it a valuable tool for scientific research, with potential applications in various fields. Further research on Recombinant Human ELMO1 could lead to a better understanding of the mechanisms of cell movement and phagocytosis, as well as the development of novel therapeutic strategies for diseases involving these processes.

ProteoGenix catalogue number ARO-P12900. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 32.20 kDa; Fragment: Arg471-Asn727; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
Engulfment and cell motility protein 1, ELMO1, Protein ced-12 homolog, KIAA0281
Host species
E. coli
Source organism
Human
Molecular weight
32.20 kDa
Sequence fragment
Arg471-Asn727
Sequence
RATSEDFNKVMQVVKEQVMRALTTKPSSLDQFKSKLQNLSYTEILKIRQSERMNQEDFQSRPILELKEKIQPEILELIKQQRLNRLVEGTCFRKLNARRRQDKFWYCRLSPNHKVLHYGDLEESPQGEVPHDSLQDKLPVADIKAVVTGKDCPHMKEKGALKQNKEVLELAFSILYDSNCQLNFIAPDKHEYCIWTDGLNALLGKDMMSDLTRNDLDTLLSMEIKLRLLDLENIQIPDAPPPIPKEPSNYDFVYDCN
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P12900
UniProt accession
Q92556
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£225.00£180.00